Clinical Trial Update: House Dust Mite SLIT in Elderly Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating house dust mite sublingual immunotherapy for elderly patients with allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• House Dust Mite SLIT (house dust mite allergen extract for sublingual immunotherapy)

Snippet

Sponsor: Medical University of Silesia | Conditions: Allergic Rhinitis | Phase 4 | Status: COMPLETED